DFT and MD simulation investigation of favipiravir as an emerging antiviral option against viral protease (3CL(pro)) of SARS-CoV-2

As per date, around 20 million COVID-19 cases reported from across the globe due to a tiny 125 nm sized virus: SARS-CoV-2 which has created a pandemic and left an unforgettable impact on our world. Besides vaccine, medical community is in a race to identify an effective drug, which can fight against...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Pooja, Rana, Meenakshi, Chowdhury, Papia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342190/
https://www.ncbi.nlm.nih.gov/pubmed/34376872
http://dx.doi.org/10.1016/j.molstruc.2021.131253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342190/
https://www.ncbi.nlm.nih.gov/pubmed/34376872
http://dx.doi.org/10.1016/j.molstruc.2021.131253

Ejemplares similares